Şahin, A. B. Et Al. 2021. Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy. SCIENTIFIC REPORTS , no.1 .

Şahin, A. B., Cubukcu, E., Ocak, B., Deligonul, A., Oyucu Orhan, S., Tolunay, S., ... Gokgoz, M. S.(2021). Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy. SCIENTIFIC REPORTS , no.1.

Şahin, AHMET Et Al. "Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy," SCIENTIFIC REPORTS , no.1, 2021

Şahin, AHMET B. Et Al. "Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy." SCIENTIFIC REPORTS , no.1, 2021

Şahin, A. B. Et Al. (2021) . "Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy." SCIENTIFIC REPORTS , no.1.

@article{article, author={AHMET BİLGEHAN ŞAHİN Et Al. }, title={Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy}, journal={SCIENTIFIC REPORTS}, year=2021}